RxDoctor Payments Data

Andrew Ju, MD

Radiation Oncology · Greenville, NCNPI 1235394081

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for radiation oncology clinicians in NC, where the typical reported total is $329.

$28in general payments, 2019–2025

Across 2 payments — averaging $14.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fortovia Therapeutics, Inc.$15
  • Elekta, Inc.$13
$210in research payments, 2019–2025

Across 1 payment — averaging $209.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$210

What the payments were for

  • Food & beverage$28100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Fortovia Therapeutics, Inc.1$15
Elekta, Inc.1$13

How this compares

$28 in reported general payments places this provider in the 10th percentile of 199 radiation oncology providers in North Carolina.

See all radiation oncology providers in North Carolina →

Medicare billing

Part B allowed, 2024
$635,160
Medicare patients
204
Services billed
3,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pilocarpine Hcl38$1,825
Lidocaine Hcl ViscousLidocaine Hcl61$1,377
Oxycodone Hcl59$1,197
Tamsulosin Hcl93$824
Pentoxifylline36$689
Silver Sulfadiazine12$146
Ondansetron OdtOndansetron13$116
Fluconazole11$85

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Greenville

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →